AMBER HILL: Open Payments
NPI 1447809579 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Novo Nordisk Inc | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Lilly USA, LLC | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| PFIZER INC. | 2 | $35 |
| Eisai Inc. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| SI-BONE, INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: Rybelsus, TRELEGY ELLIPTA, Kerendia, FARXIGA, MOUNJARO, Leqembi, CAPVAXIVE, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
